{"id":"W2619448414","doi":"10.1016/s2213-8587(17)30138-9","title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":961,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; Université Laval","funders":"","keywords":"Denosumab; Medicine; Placebo; Osteoporosis; Adverse effect; Incidence (geometry); Femoral neck; Randomized controlled trial; Bristol-Myers; Clinical endpoint; Physical therapy; Internal medicine; Surgery; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07123181860959384,"score_gpt":0.3673927548464625,"score_spread":0.2961609362368687,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}